Drug Type Bacteriophage therapy |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vancomycin-resistant enterococcal infection | Phase 2 | US | 25 Oct 2023 | |
Enterococcus faecium infection | Discovery | US | 22 Jan 2020 |